Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Research article

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score

Authors: Mohammed Ibn-Mas’ud Danjuma, Hussam Almasri, Shaikha Alshokri, Fadi Khazahia Khir, Ashraf Elmalik, Naim Ghazi Battikh, Ibtihal Mahmoud Hassan Abdallah, Mohamed Elshafei, Haajra Fatima, Mouhand Faisal Hamad Mohamed, Yahya Maghoub, Tanweer Hussain, Ijaz Kamal, Zubair Anwer, Mubarak Ariyo Bidmos, Abdel-Naser Elzouki

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Drug-induced liver injury (DILI) represents an increasing morbidity in the general population, but more so in the elderly cohort of patients. Despite this, the concept of its prevention through prospective analysis has largely remained unexamined. We evaluated the utility of recently validated adverse drug reactions (ADR) avoidability tool in a cohort of elderly patients with DILI.

Methods

We examined 38 DILI-drug pairs from n=38 patients in a prospective cohort of patients presenting with adverse drug reactions to a Weill Cornell-affiliated tertiary hospital between February 2019 and January 2020. DILI outcomes were adjudicated by the updated Roussel Uclaf Causality Assessment Method (RUCAM). Two clinical pharmacologists and two general physicians utilized the Liverpool adverse drug reactions avoidability tool (LAAT) and the modified Hallas tools to rate the preventability of DILI-drug pairs. Inter-rater, exact agreement proportions, as well as intraclass correlation coefficients were generated and expressed as ordinal outcomes.

Results

The cases examined for the determination of DILI avoidability had probability likelihood of “probable” or “highly probable” by the updated RUCAM scale. Examination of the 38 DILI-drug pairs (n= 38 patients) resulted in a total of 152 ordinal outcome decisions. We found about 32.3% (50/152) and 34.2% (52/152) of DILI-drug pairs were rated as “avoidable” (“probable” or “definite”) by the LAAT and the modified Hallas tools respectively. The overall median Krippendorf’s kappa with the LAAT was 0.61 (SE 0.12, CI 0.36, 0.85) and for modified Hallas tool was 0.53 (SE 0.18; CI 0.16, 0.89). The inter-rater correlation coefficient (ICC) for the LAAT and modified Hallas were 0.50 [0.32, 0.65] and 0.63 [0.48, 0.76] respectively. Exact pairwise agreement was present in 30/38 (IQR 29.5, 34.5), and 28/38 (IQR 27.5-35.5) of DILI-ADR pairs using the LAAT and modified Hallas tools respectively.

Conclusion

We found a significant proportion of drug-induced liver injury adjudicated by the updated RUCAM scale in elderly hospitalized cohort of patients were avoidable with significant implication for therapeutic commissioning as well as cost effectiveness interventions in this cohort of patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Fountain FF, Tolley E, Chrisman CR, Self TH. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest. 2005;128(1):116–23.CrossRef Fountain FF, Tolley E, Chrisman CR, Self TH. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic. Chest. 2005;128(1):116–23.CrossRef
2.
go back to reference Stine JG, Sateesh P, Lewis JH. Drug-Induced Liver Injury in the Elderly. Curr Gastroenterol Rep [Internet]. 2012;15(1):299 Available from: https://doi.org/10.1007/s11894-012-0299-8.CrossRef Stine JG, Sateesh P, Lewis JH. Drug-Induced Liver Injury in the Elderly. Curr Gastroenterol Rep [Internet]. 2012;15(1):299 Available from: https://​doi.​org/​10.​1007/​s11894-012-0299-8.​CrossRef
4.
go back to reference Danjuma MI-M, Sajid J, Fatima H, Elzouki A-N. Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends. Medicine (Baltimore). 2019;98(50):e18322.CrossRef Danjuma MI-M, Sajid J, Fatima H, Elzouki A-N. Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends. Medicine (Baltimore). 2019;98(50):e18322.CrossRef
5.
go back to reference Herrlinger C, Klotz U. Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol. 2001;15(6):897–918.CrossRef Herrlinger C, Klotz U. Drug metabolism and drug interactions in the elderly. Best Pract Res Clin Gastroenterol. 2001;15(6):897–918.CrossRef
6.
go back to reference Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21.CrossRef Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology. 2005;129(2):512–21.CrossRef
7.
go back to reference Danjuma MI-M, Al SS, Abubeker IY, El MA, Abdallah IMH, El SMN, et al. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools. Medicine (Baltimore). 2020;99(1):e18569.CrossRef Danjuma MI-M, Al SS, Abubeker IY, El MA, Abdallah IMH, El SMN, et al. An investigation into the avoidability of adverse drug reactions using the LAAT and modified Hallas tools. Medicine (Baltimore). 2020;99(1):e18569.CrossRef
8.
go back to reference Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.CrossRef Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228(2):83–90.CrossRef
9.
go back to reference Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, et al. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool. PLoS One [Internet]. 2017;12(1):e0169393 Available from: https://www.ncbi.nlm.nih.gov/pubmed/28046035.CrossRef Bracken LE, Nunn AJ, Kirkham JJ, Peak M, Arnott J, Smyth RL, et al. Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool. PLoS One [Internet]. 2017;12(1):e0169393 Available from: https://​www.​ncbi.​nlm.​nih.​gov/​pubmed/​28046035.​CrossRef
10.
go back to reference Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci [Internet]. 2015;17(1):14.CrossRef Danan G, Teschke R. RUCAM in Drug and Herb Induced Liver Injury: The Update. Int J Mol Sci [Internet]. 2015;17(1):14.CrossRef
11.
go back to reference Mouton JP, Mehta U, Rossiter DP, Maartens G, Cohen K. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system. PLoS One. 2017;12(2):e0172830.CrossRef Mouton JP, Mehta U, Rossiter DP, Maartens G, Cohen K. Interrater agreement of two adverse drug reaction causality assessment methods: A randomised comparison of the Liverpool Adverse Drug Reaction Causality Assessment Tool and the World Health Organization-Uppsala Monitoring Centre system. PLoS One. 2017;12(2):e0172830.CrossRef
12.
go back to reference Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323–30.CrossRef Danan G, Benichou C. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993;46(11):1323–30.CrossRef
13.
go back to reference Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–25 1425.e1-3; quiz e19-20.CrossRef Bjornsson ES, Bergmann OM, Bjornsson HK, Kvaran RB, Olafsson S. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419–25 1425.e1-3; quiz e19-20.CrossRef
14.
go back to reference Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet. 1988;15(5):287–94.CrossRef Woodhouse KW, Wynne HA. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet. 1988;15(5):287–94.CrossRef
Metadata
Title
Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
Authors
Mohammed Ibn-Mas’ud Danjuma
Hussam Almasri
Shaikha Alshokri
Fadi Khazahia Khir
Ashraf Elmalik
Naim Ghazi Battikh
Ibtihal Mahmoud Hassan Abdallah
Mohamed Elshafei
Haajra Fatima
Mouhand Faisal Hamad Mohamed
Yahya Maghoub
Tanweer Hussain
Ijaz Kamal
Zubair Anwer
Mubarak Ariyo Bidmos
Abdel-Naser Elzouki
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01732-3

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue